EMA Cancer Medicines Forum (CMF) meeting with industry stakeholders on cancer treatment optimisation

• Date:
  Reede, 14 november 2025 , 13:30 - 17:30 Amsterdam time (CET)
• Asukoht:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The EMA Cancer Medicines Forum (CMF) is organising a workshop on 14 November 2025 to enable industry support for cancer treatment optimisation.

This workshop is organised to discuss:

• The industry support for cancer treatment optimisation from innovation to practice and to enable a stakeholder dialogue. 
• Opportunities for industry to support treatment optimisation both during development and after marketing authorisation.

Topics to be explored include dose optimisation, rewarding mechanism for post-marketing studies, industry’s role in supporting optimisation post-approval, data and tissue sharing.

The workshop concludes with recommendations about priorities for further collaboration between industry and academia in the context of the CMF.

Video recording

Documents

Agenda - EMA Cancer Medicines Forum (CMF) meeting with industry stakeholders on cancer treatment optimisation

Presentation - Balancing innovation and access insights from AIM’s (J. Stokx)

Presentation - Collaborative models with academia and research institutions/groups (D. Lacombe)

Presentation - Context setting on CMF initiatives and industry roles (D. Burcoveanu, M. Zaiac)

Presentation - Incentives to support post-marketing research (F. Nissen)

Presentation - Incentives to support post marketing research - industry view (M. Akimov)

Presentation - Industry support for pragmatic trials (N. Kronidou)

Presentation - Innovative reward mechanism (S. van Waalwijk van Doorn-Khosrovani)

Presentation - Opportunities in sharing molecular clinical data (J. Bergh)

Presentation - Should dose finding be concluded pre or post approval? (O. Tenhunen)